Ermenegildo Zegna NV
ZGN
Hutchmed (China)
HCM
eBay
EBAY
Enerpac Tool
EPAC
Halozyme Therapeutics
HALO
US Stock MarketDetailed Quotes
SLRN Acelyrin
- 2.640
- +0.100+3.94%
Close Mar 27 16:00 ET
265.87MMarket Cap-1.06P/E (TTM)
2.660High2.530Low451.18KVolume2.540Open2.540Pre Close1.18MTurnover0.62%Turnover RatioLossP/E (Static)100.71MShares7.25052wk High0.58P/B191.64MFloat Cap1.84552wk Low--Dividend TTM72.59MShs Float29.880Historical High--Div YieldTTM5.12%Amplitude1.845Historical Low2.625Avg Price1Lot Size
Acelyrin News
Insider Stock Sales Shake Up ACELYRIN, INC.
Insider Sale: Chief Executive Officer of $SLRN Sells 17,986 Shares
Acelyrin | 10-K: FY2024 Annual Report
Acelyrin Adopts Poison Pill as Tang Capital Partners Builds Stake
Acelyrin Adopts Stockholder Rights Plan; Shares Up Pre-Bell
Express News | ACELYRIN Adopts Limited-Duration Stockholder Rights Plan
Express News | ACELYRIN Shares Down 6.5% After Co Reiterates Merger With Alumis
Express News | Refile-Buzz-ACELYRIN Slides After Reiterating Merger With Alumis Amid Concentra's Buyout Offer
Acelyrin Falls as Acelyrin Reaffirms Deal Commitment
Acelyrin Says Concentra Indication Not Expected to Result in Superior Proposal
Acelyrin and Alumis: Combined Company to Benefit From Differentiated Late-Stage Portfolio of Therapies and Strong Balance Sheet
ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger
Press Release: ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger
Press Release: Alumis and ACELYRIN Reaffirm Strategic and Financial Rationale of Proposed Merger
Top-rated Biotechs With Negative Enterprise Values
Key Deals This Week: Howard Hughes, Shift4 Payments, Herc Holdings, Celsius and More
Acelyrin (SLRN) Stock Surges After Unsolicited Buyout Proposal
Acelyrin Stock Jumps on Concentra Acquisition Interest
Reported Earlier, ACELYRIN Confirms Unsolicited $3/Share Offer From Concentra Biosciences Amid Pending Alumis Merger
Express News | ACELYRIN Confirms Receipt of Unsolicited Indication of Interest From Concentra Biosciences